Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,760.00
0.00 (0.00%)
At close: Feb 19, 2026

KOSDAQ:072020 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2022FY 2021FY 2020FY 2012FY 2011
Period Ending
Mar '23 Dec '22 Dec '21 Dec '20 Dec '12 Dec '11
Cash & Equivalents
13,0007,84811,33712,2821,9651,666
Short-Term Investments
5,1387,9176,7668,262394.98219.1
Trading Asset Securities
-2,2223,3652,224--
Cash & Short-Term Investments
18,13817,98721,46822,7672,3601,885
Cash Growth
-9.16%-16.22%-5.71%864.70%25.20%-87.19%
Accounts Receivable
4,5223,2163,3482,1971,1751,240
Other Receivables
276.96185.2994.53848.96--
Receivables
4,7993,4013,4423,0621,1751,240
Inventory
18,41417,91814,61315,9236,3034,503
Other Current Assets
308.21283.95320.03588.899,43315,064
Total Current Assets
41,65939,59039,84442,34219,27122,692
Property, Plant & Equipment
66,34966,96966,09157,89129,17417,426
Long-Term Investments
2,9714,4114,0363,403248.29199.29
Other Intangible Assets
271.27292.52307.2386.31823.571,112
Long-Term Deferred Tax Assets
1,7781,8912,419857.21677.43565.84
Long-Term Deferred Charges
137.01146.1218.2759.5--
Other Long-Term Assets
1,5331,559237.548.49622.98413.44
Total Assets
114,699114,859112,952104,97950,81742,408
Accounts Payable
332.57443.4607.33442.54189.42181.5
Accrued Expenses
1,6482,0212,3072,834--
Short-Term Debt
6,0956,4296,4295,4071,159175.26
Current Portion of Leases
123.91140.95120.52121.75--
Current Income Taxes Payable
294.92291.02361.03-385.47374.32
Other Current Liabilities
4,9133,9884,5363,6483,0711,199
Total Current Liabilities
13,40713,31314,36112,4544,8051,930
Long-Term Debt
4,7625,7865,2144,6431,500-
Long-Term Leases
166.96188.96126.0389.48--
Pension & Post-Retirement Benefits
-0--243.56390.97394.74
Other Long-Term Liabilities
277.99266.53274.69-0--
Total Liabilities
18,61419,55419,97617,4296,6962,325
Common Stock
4,9804,9804,9804,9803,6603,660
Additional Paid-In Capital
26,02326,02326,02326,0239,9169,916
Retained Earnings
69,26368,37664,97557,96130,53026,493
Treasury Stock
-4,123-4,042-3,001-1,414--
Comprehensive Income & Other
-57.14-32.01-0.26015.2614.06
Shareholders' Equity
96,08595,30492,97687,55044,12140,083
Total Liabilities & Equity
114,699114,859112,952104,97950,81742,408
Total Debt
11,14812,54411,88910,2612,659175.26
Net Cash (Debt)
6,9905,4439,57912,506-299.071,710
Net Cash Growth
-17.12%-43.18%-23.41%---88.30%
Net Cash Per Share
718.66558.13973.061265.87-34.03194.39
Filing Date Shares Outstanding
9.669.679.769.868.818.75
Total Common Shares Outstanding
9.669.679.769.868.818.75
Working Capital
28,25226,27725,48229,88814,46520,761
Book Value Per Share
9948.049859.429527.518880.485010.154579.98
Tangible Book Value
95,81495,01292,66987,16443,29738,971
Tangible Book Value Per Share
9919.969829.169496.038841.304916.634452.89
Land
5,3745,3745,3746,278--
Buildings
37,39037,39031,88116,619--
Machinery
36,76536,76536,25528,692--
Construction In Progress
2,2091,3701,80524,507--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.